TY - JOUR
T1 - Long-term quality of life after radical prostatectomy in wives of men in the postoperative adjuvant androgen deprivation trial
AU - Sterba, Katherine Regan
AU - Swartz, Richard J.
AU - Basen-Engquist, Karen
AU - Black, Peter C.
AU - Pettaway, Curtis A.
N1 - Funding Information:
Acknowledgments Patients in the PAAD Trial received free study drug from TAP Pharmaceutical (Lake Forest, IL, USA), AstraZeneca (Wilmington, DE, USA), or Schering Plough (Kenilworth, NJ, USA). First author’s work was supported by an NCI Cancer Prevention and Control Training Program, Center for Health Promotion and Prevention Research, University of Texas-Houston School of Public Health– National Cancer Institute/NIH Grant #2R25CA57712. Second author’s work was supported by an NCI K07 career development award (K07 CA113641). Fourth author’s work was supported by an NIH T32 Training Grant (CA079449) and an American Urological Association Foundation Scholarship.
PY - 2011/8
Y1 - 2011/8
N2 - Purpose: We examined quality of life in spouses of men in the Post-Adjuvant Androgen Deprivation trial after radical prostatectomy. Methods: Men at high risk of prostate cancer recurrence were randomized to receive androgen deprivation therapy or observation. Forty-three couples completed telephone interviews every 6 months for 2 years assessing women's mood disturbance, mental and physical health, and sexual function and bother as well as men's symptoms and sociodemographic and marital variables. We used linear mixed modeling to explore relationships between wives' quality of life and time, treatment group, and men's symptoms. Results: Women's mental health functioning improved over time (p<0.05). Furthermore, women with husbands in the observation group had worse mood disturbance (p=0.01) and poorer mental health (p=0.02) than women with husbands in treatment. Men's symptoms were associated with worse physical health in wives (p=0.02). Women also reported worse sexual function at 18 and 24 months compared with baseline (p=0.02), but ratings of sexual bother were unrelated to time, treatment, and symptoms. Conclusions: These exploratory results are consistent with research demonstrating that spousal cancer-related distress decreases over time. Treatment group differences suggest that an examination of caregiving in the context of uncertainty is warranted. Also, the physical burden of caregiving may intensify when men have more symptoms. To inform interventions, future studies should clarify how treatment and symptoms influence wives' distress by examining expectations and communication.
AB - Purpose: We examined quality of life in spouses of men in the Post-Adjuvant Androgen Deprivation trial after radical prostatectomy. Methods: Men at high risk of prostate cancer recurrence were randomized to receive androgen deprivation therapy or observation. Forty-three couples completed telephone interviews every 6 months for 2 years assessing women's mood disturbance, mental and physical health, and sexual function and bother as well as men's symptoms and sociodemographic and marital variables. We used linear mixed modeling to explore relationships between wives' quality of life and time, treatment group, and men's symptoms. Results: Women's mental health functioning improved over time (p<0.05). Furthermore, women with husbands in the observation group had worse mood disturbance (p=0.01) and poorer mental health (p=0.02) than women with husbands in treatment. Men's symptoms were associated with worse physical health in wives (p=0.02). Women also reported worse sexual function at 18 and 24 months compared with baseline (p=0.02), but ratings of sexual bother were unrelated to time, treatment, and symptoms. Conclusions: These exploratory results are consistent with research demonstrating that spousal cancer-related distress decreases over time. Treatment group differences suggest that an examination of caregiving in the context of uncertainty is warranted. Also, the physical burden of caregiving may intensify when men have more symptoms. To inform interventions, future studies should clarify how treatment and symptoms influence wives' distress by examining expectations and communication.
KW - Partners
KW - Prostate cancer
KW - Quality of life
KW - Symptoms
UR - http://www.scopus.com/inward/record.url?scp=80051587733&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80051587733&partnerID=8YFLogxK
U2 - 10.1007/s00520-010-0916-8
DO - 10.1007/s00520-010-0916-8
M3 - Article
C2 - 20499107
AN - SCOPUS:80051587733
SN - 0941-4355
VL - 19
SP - 1117
EP - 1124
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 8
ER -